tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Rigel Pharmaceuticals price target raised to $38 from $32 at Cantor Fitzgerald
PremiumThe FlyRigel Pharmaceuticals price target raised to $38 from $32 at Cantor Fitzgerald
29d ago
Rigel Pharmaceuticals Reports Strong Q3 2025 Results
Premium
Company Announcements
Rigel Pharmaceuticals Reports Strong Q3 2025 Results
29d ago
Rigel Pharmaceuticals reports Q3 EPS $1.46, consensus 94c
Premium
The Fly
Rigel Pharmaceuticals reports Q3 EPS $1.46, consensus 94c
30d ago
Eli Lilly and Rigel’s Promising Study on Rheumatoid Arthritis Treatment
PremiumCompany AnnouncementsEli Lilly and Rigel’s Promising Study on Rheumatoid Arthritis Treatment
3M ago
Rigel Pharmaceuticals’ Earnings Call Highlights Robust Growth
Premium
Company Announcements
Rigel Pharmaceuticals’ Earnings Call Highlights Robust Growth
4M ago
Rigel’s Strong Financial Performance and Promising Growth Prospects Drive Buy Rating
Premium
Ratings
Rigel’s Strong Financial Performance and Promising Growth Prospects Drive Buy Rating
4M ago
Eli Lilly and Rigel Pharmaceuticals: Promising Advances in Rheumatoid Arthritis Treatment
PremiumCompany AnnouncementsEli Lilly and Rigel Pharmaceuticals: Promising Advances in Rheumatoid Arthritis Treatment
4M ago
Eli Lilly and Rigel Pharmaceuticals Advance Rheumatoid Arthritis Study with LY3871801
Premium
Company Announcements
Eli Lilly and Rigel Pharmaceuticals Advance Rheumatoid Arthritis Study with LY3871801
4M ago
Promising Efficacy and Market Potential for GAVRETO in RET Fusion-Positive Tumors
Premium
Ratings
Promising Efficacy and Market Potential for GAVRETO in RET Fusion-Positive Tumors
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100